| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Clofarabine | Clofarabine (1138620) | PVE00155 | View CAS 123318-82-1 |
| Clofarabine | Clofarabine Alpha Anomer | VE0015987 | View CAS 491594-60-6 |
| Clofarabine | Clofarabine beta-Pyranosyl Formamide Impurity | VE008549 | View CAS 1140251-33-7 |
[rfq_list]
| Catalogue No. | VE008549 |
| CAS No. | 1140251-33-7 |
| Molecular Formula | C10H13ClFN5O4 |
| Molecular Weight | 321.69 g/mol |
| Parent drug | Clofarabine |
| IUPAC Name | N-(4-Amino-2-chloro-6-((2R, 3R, 4R, 5R)-3-fluoro-4, 5-dihydroxy-tetrahydro-2H-pyran-2-ylamino)pyrimidin-5-yl)formamide |
| Synonyms | N/A |
| References | Ghanem, H., Kantarjian, H., Ohanian, M., & Jabbour, E. (2012). The role of clofarabine in acute myeloid leukemia. Leukemia & Lymphoma, 54(4), 688–698. https://doi.org/10.3109/10428194.2012.726722 |
| Status | In-stock |
| ListName | Clofarabine beta-Pyranosyl Formamide Impurity |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
